| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |